BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30617409)

  • 1. MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis.
    Cocozza S; Pontillo G; Lanzillo R; Russo C; Petracca M; Di Stasi M; Paolella C; Vola EA; Criscuolo C; Moccia M; Lamberti A; Monti S; Brescia Morra V; Elefante A; Palma G; Tedeschi E; Brunetti A
    Neuroradiology; 2019 Feb; 61(2):155-162. PubMed ID: 30617409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.
    Tedeschi E; Palma G; Canna A; Cocozza S; Russo C; Borrelli P; Lanzillo R; Angelini V; Postiglione E; Morra VB; Salvatore M; Brunetti A; Quarantelli M
    Eur Radiol; 2016 Dec; 26(12):4577-4584. PubMed ID: 26905870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
    Eisele P; Alonso A; Szabo K; Ebert A; Ong M; Schoenberg SO; Gass A
    Medicine (Baltimore); 2016 Sep; 95(39):e4624. PubMed ID: 27684794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
    Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
    AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium deposition in the paediatric brain: T1-weighted hyperintensity within the dentate nucleus following repeated gadolinium-based contrast agent administration.
    Young JR; Orosz I; Franke MA; Kim HJ; Woodworth D; Ellingson BM; Salamon N; Pope WB
    Clin Radiol; 2018 Mar; 73(3):290-295. PubMed ID: 29208312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
    Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
    Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
    Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
    Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression.
    Preziosa P; Pagani E; Meani A; Moiola L; Rodegher M; Filippi M; Rocca MA
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35105685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients.
    Kühn I; Maschke H; Großmann A; Hauenstein K; Weber MA; Zettl UK; Storch A; Walter U
    Neurol Sci; 2022 Apr; 43(4):2631-2639. PubMed ID: 34735650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium MRI of T1 High Signal Intensity in the Dentate Nucleus due to Gadolinium Deposition in Multiple Sclerosis.
    Eisele P; Konstandin S; Szabo K; Ong M; Zöllner F; Schad LR; Schoenberg SO; Gass A
    J Neuroimaging; 2017 Jul; 27(4):372-375. PubMed ID: 28569398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
    Jaulent P; Hannoun S; Kocevar G; Rollot F; Durand-Dubief F; Vukusic S; Brisset JC; Sappey-Marinier D; Cotton F
    Eur J Radiol; 2018 Aug; 105():204-208. PubMed ID: 30017281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
    Thaler C; Faizy T; Sedlacik J; Holst B; Stellmann JP; Young KL; Heesen C; Fiehler J; Siemonsen S
    PLoS One; 2015; 10(12):e0144693. PubMed ID: 26659852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
    Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
    Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Disability and Brain MRI Volumetry Results among Multiple Sclerosis Patients during 5-Year Follow-Up.
    Strautmane S; Balodis A; Teivane A; Grabovska D; Naudins E; Urbanovics D; Fisermans E; Mednieks J; Flintere-Flinte A; Priede Z; Millers A; Zolovs M
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374286
    [No Abstract]   [Full Text] [Related]  

  • 16. Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
    Schlemm L; Chien C; Bellmann-Strobl J; Dörr J; Wuerfel J; Brandt AU; Paul F; Scheel M
    Mult Scler; 2017 Jun; 23(7):963-972. PubMed ID: 27679460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
    Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.
    Zivadinov R; Bergsland N; Hagemeier J; Ramasamy DP; Dwyer MG; Schweser F; Kolb C; Weinstock-Guttman B; Hojnacki D
    Neurology; 2019 Aug; 93(6):e611-e623. PubMed ID: 31285398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a.
    Gasperini C; Paolillo A; Giugni E; Galgani S; Bagnato F; Mainero C; Onesti E; Bastianello S; Pozzilli C
    Mult Scler; 2002 Apr; 8(2):119-23. PubMed ID: 11990868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis.
    Scaravilli A; Tranfa M; Pontillo G; Falco F; Criscuolo C; Moccia M; Monti S; Lanzillo R; Brescia Morra V; Palma G; Petracca M; Tedeschi E; Elefante A; Brunetti A; Cocozza S
    AJNR Am J Neuroradiol; 2023 Apr; 44(4):396-402. PubMed ID: 36863844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.